Beyond The Abstract: Metastatic Adenocarcinoma After Augmentation Gastrocystoplasty

Main Category: Urology / Nephrology
Article Date: 02 Mar 2008 - 0:00 PDT

email to a friend   printer friendly   view / write opinions

UroToday.com - The authors believe that this case series highlights a concern that was once theoretical and now appears real: the ideal screening regimen and the true incidence of malignancy in patients who have undergone bladder augmentation remain unknown.

We believe the establishment of a national registry would allow for a more accurate determination of the cancer incidence and the efficacy of screening protocols for these patients. We hope that our work and work by other investigators in this field will lead to the establishment of a national registry, and, ultimately, better care for these patients.

Written by Vijaya M. Vemulakonda, MD, JD, as part of Beyond the Abstract on UroToday.com. This initiative offers a method of publishing for the professional urology community. Authors are given an opportunity to expand on the circumstances, limitations, etc., of their research by referencing the published abstract.

Link to full abstract

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

----------------------------
Copyright © 2007 - UroToday
Reproduced for Medical News Today with permission of UroToday.
----------------------------